BPG is committed to discovery and dissemination of knowledge
Articles in Press
3/27/2026 9:19:55 AM | Browse: 3 | Download: 0
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Basic Study |
| Article Title |
Matrix metalloproteinase 3 facilitates colorectal cancer progression by enhancing cell proliferation and invasion
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Bin-Bin Du, Zheng-Peng Qian, Cheng-Zhang Zhu and Quan-Lin Guan |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Department of Health Commission of Gansu Province |
No.GSWSKY2024-12 |
| Gansu Provincial Administration of Traditional Chinese Medicine |
GZKJ-2024-64 |
|
| Corresponding Author |
Quan-Lin Guan, Chief, PhD, Professor, The First School of Clinical Medical, Lanzhou University, No. 222 Tianshui South Road, Chengguan District, Lanzhou 730000, Gansu Province, China. guanql@lzu.edu.cn |
| Key Words |
Matrix metalloproteinase 3; Colorectal cancer; Endothelial PAS domain protein 1; Tumor progression; Biomarker |
| Core Tip |
Matrix metalloproteinase 3 (MMP3) is significantly overexpressed in colorectal cancer (CRC) tissues and cells, which is closely associated with advanced tumor stage, lymph node metastasis, nerve invasion and worse overall survival. Functional experiments demonstrate that MMP3 promotes CRC cell proliferation, migration, invasion and represses apoptosis. Using proteomic analysis and in vivo xenograft models, we identify and verify endothelial PAS domain protein 1 (EPAS1) as a critical downstream target of MMP3. MMP3 facilitates CRC progression by regulating EPAS1 expression, suggesting that MMP3 may serve as a novel prognostic biomarker and potential therapeutic target for CRC. |
| Citation |
Du BB, Qian ZP, Zhu CZ, Guan QL. Matrix metalloproteinase 3 facilitates colorectal cancer progression by enhancing cell proliferation and invasion. World J Gastroenterol 2026; In press |
 |
Received |
|
2026-01-23 05:53 |
 |
Peer-Review Started |
|
2026-01-23 05:54 |
 |
First Decision by Editorial Office Director |
|
2026-02-04 10:08 |
 |
Return for Revision |
|
2026-02-04 10:08 |
 |
Revised |
|
2026-02-06 10:08 |
 |
Publication Fee Transferred |
|
2026-02-09 06:35 |
 |
Second Decision by Editor |
|
2026-03-27 02:35 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-03-27 09:19 |
 |
Articles in Press |
|
2026-03-27 09:19 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345